ISR Perspective Therapeutics Inc Compare

yahoo

Was IsoRay Inc’s Earnings Decline A Part Of Broader Industry Downturn?

yahoo

IsoRay, Inc. :ISR-US: Earnings Analysis: Q1, 2018 By the Numbers : December 1, 2017

yahoo

IsoRay reports 1Q loss

seekingalpha

IsoRay's CEO Dana Landry on F1Q 2018 Results - Earnings Call Transcript

reuters

IsoRay Q1 loss per share $0.03

reuters

IsoRay Inc announces the launch of a Phase II, multicenter clinical trial

yahoo

IsoRay Announces First Quarter Fiscal 2018 Earnings Conference Call

yahoo

Is There Now An Opportunity In IsoRay Inc ?

yahoo

Should You Sell IsoRay Inc For This Reason?

yahoo

IsoRay reports 4Q loss

reuters

Isoray Q4 loss per share $0.03

yahoo

IsoRay Announces Fourth Quarter Fiscal 2017 Revenue of $1.37 Million, 22% Fourth Quarter-over-Fourth Quarter Increase

yahoo

IsoRay Announces Study Accepted for Publication in the International Journal of Radiation Oncology, Biology, Physics entitled "Re-irradiation using Permanent Interstitial Brachytherapy : A Potentially Durable Technique for Salvaging Recurrent Pelvic Malignancies"

yahoo

IsoRay Announces "Long-term PSA Outcomes in a Single Institution, Prospective Randomized Cesium-131 / Iodine-125 Permanent Prostate Brachytherapy Trial" Poster Presentation at 2017 Annual American Society for Radiation Oncology Conference

seekingalpha

Your Daily Pharma Scoop: Nabriva's Further Potential, Allergan's IP Gimmick ...

yahoo

Is IsoRay Inc Undervalued?

yahoo

IsoRay Announces Participation At The 19th Annual Rodman & Renshaw Global Investment Conference In New York City September 10-12, 2017

reuters

Isoray Inc's unit enters into consignment agreement

reuters

IsoRay Q4 revenue rises 22 pct to $1.37 mln

yahoo

IsoRay Announces Preliminary Fourth Quarter F2017 Revenue of $1.37 Million, 22% Year-over-Year Increase

yahoo

New Study Shows Brachytherapy And Cesium-131 Isotope Treatment Beneficial For Prostate Cancer Patients

yahoo

IsoRay Announces Appointment of Mark Austin as Controller, Principal Accounting and Financial Officer

reuters

BRIEF-Isoray receives FDA response to application for Gammatile

yahoo

IsoRay Receives FDA Response to 510 Application for GammaTile™

reuters

Isoray receives FDA response to application for Gammatile

yahoo

IsoRay Announces Study Published in The International Journal of Radiation Oncology, Biology, Physics entitled, "Clinical Outcomes of Large Brain Metastases Treated with Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial"

reuters

BRIEF-IsoRay Q3 loss per share $0.02

reuters

IsoRay Q2 loss per share $0.03